$Ginkgo Bioworks(DNA.US) bought 10,000 shares a long time ago, and finally broke even today. The uncertainty is still very high. Not only can we not see any signs of profitability at the moment, but we even have to worry about whether the cash flow is enough to burn. However, the good thing is that the company has significantly optimized its cash flow expenditure and can still hold on for a long time. Given the rise of coding agents and my own good experience with them, I think AI will eventually extend to biological sciences. The cooperation with OpenAI has shown me this promising future. I'll treat it as a venture capital investment and hold it for a while to see the composition. 😂